Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
LAMISIL AT CREAM |
| Manufacturer |
|
Novartis Consumer Health |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Allylamine antifungal. |
| Generic Name |
|
Terbinafine (as HCl) 1%. |
| Also |
• LAMISIL AT SOLUTION
• LAMISIL SOLUTION
|
| Indications |
|
Tinea pedis, t. corporis, t. cruris. |
| Children |
|
Not recommended. |
| Adults |
|
Apply twice daily (AM & PM). Improvement may continue for 2–6 weeks after therapy completed. T. pedis (interdigital), t. corporis, t. cruris: apply for 1 week. T. pedis (bottom or sides of feet): apply for 2 weeks. |
| Precautions |
|
Avoid eyes, nose, mouth, other mucous membranes, scalp, nails, and use of occlusive dressings. Do not use soln spray on face. Discontinue if irritation or sensitivity develops. Pregnancy (Cat.B). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Local irritation, burning, itching, dryness. Soln: also skin exfoliation, erythmatous rash. |
| How Supplied |
Soln—30mL (pump spray)
Crm—12g, 24g
AT Soln—30mL (pump spray or dropper) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
